Response of symptomatic myocardial ischemia in ischemic cardiomyopathy to intensive vasodilator therapy

T B Levine1, A B Levine, A Vincenzi

  • 1Division of Cardiology, Henry Ford Hospital, Detroit, Michigan 48202, USA.

Insights

Angiotensin-converting enzyme inhibitors and nitrates significantly improve heart failure symptoms and reduce ischemia in patients with ischemic cardiomyopathy and angina. This vasodilator therapy offers cardiovascular protection by mitigating ischemia-related events.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Ischemic cardiomyopathy and ongoing angina pectoris present significant cardiovascular risks.
  • Angiotensin-converting enzyme (ACE) inhibitors are known for their role in cardiovascular protection.

Purpose of the Study:

  • To evaluate the cardiovascular protective effects of ACE inhibitors.
  • To assess the response to intensive vasodilator therapy in patients with ischemic cardiomyopathy and active angina.

Main Methods:

  • Patients with ischemic cardiomyopathy and ongoing angina pectoris received intensive vasodilator therapy.
  • The therapy regimen included angiotensin-converting enzyme inhibition and nitrates.

Main Results:

  • Intensive vasodilator therapy improved heart failure-related symptoms.
  • Significant reduction in symptomatic ischemia was observed.
  • Ischemia-related morbid events were significantly reduced.

Conclusions:

  • Intensive vasodilator therapy with ACE inhibitors and nitrates provides cardiovascular protection.
  • This therapeutic approach is effective in managing heart failure symptoms and reducing ischemia in affected patients.

Related Concept Videos

Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...